For full functionality of this website it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser

Session Details

Concurrent Session: Game-changers for Optimizing Operations at Cell Therapy Processing Facilities
Friday, September 8, 2023 04:45 PM - 05:45 PM  
335 AB
Chair
Elena Maryamchik, MD, MBA, Memorial Sloan Kettering Cancer Center

Speakers
Yongping Wang, MD, PhD, Children’s Hospital of Philadelphia, USA – Strategies to Grow a Cell Therapy Lab, Pain Included
Emily Hopewell, PhD, Indiana University, USA – Being Flexible – Managing Operations and Maintaining Safety
Karen Moniz, MHA, ICCBBA, USA – Implementing the ISBT 128 Chain of Identity Identifier 


Description of current model of processing facilities, challenges with existing model, innovative solutions to overcome these challenges and tying these solutions to business sustainability

Session Objectives
  1. To highlight common challenges to the operations of cell therapy laboratories.
  2. To present potential solutions to address those challenges.
  3. To discuss strategies for sustainable growth of cell therapy laboratories.
  4. Bonus feature: Updates on the new ISBT 128 Chain of Identity Identifier Standard and the Hybrid Label for Collections for Cell Therapy Manufacturing Standard.

Elena Maryamchik MD, MBA
Director of Cell Therapy Laboratory and Assistant Attending in Transfusion Medicine
Memorial Sloan Kettering Cancer Center
Chair


Emily Hopewell PhD, BSc, BA
Director of Cell and Gene Therapy Manufacturing, Assistant Professor
Indiana University
Speaker


Karen Moniz MHA
Technical Director
ICCBBA
Speaker


Yongping Wang
Associate Professor of Clinical Pathology and Laboratory Medicine
Children’s Hospital of Philadelphia
Speaker